The Australian Liver Cancer market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
In 2018, liver cancer was the 7th most common cause of cancer death in Australia. Liver cancer occurs when abnormal cells within the liver grow in an uncontrolled way. There are two main types of liver cancer which are named after the part of the liver cancer first develops in, they are Hepatocellular carcinoma, & Cholangiocarcinoma. Liver cancer can either be primary or metastatic. Metastatic liver cancer is much more common than primary liver cancer in Australia. It occurs when cancer cells traveling through the blood from other gastrointestinal organs, like the colon or stomach, become lodged in the liver and become tumorous. These cancer cells can also spread in the lymphatic system. People with cirrhosis of the liver or those who have been infected with a hepatitis virus have a higher risk of getting primary liver cancer.
The market size drivers for the growth of Liver cancer diagnostics are expected to propel by rising in the number of cigarette smokers, & growing R&D investments and reimbursement policies. Factors such as the rising incidence of liver cancer and growing research activities for developing novel treatments coupled with increasing government funding for cancer treatment research are driving the liver cancer treatment market.
Daily smoking rates in Australia are around the lowest among Organisation for Economic Cooperation and Development (OECD) countries—11.2% for Australians aged 15 and over in 2019. Of the population, aged 14 and over, around three-quarters (77%) had consumed a full serve of alcohol in the previous 12 months, and 23% had not consumed alcohol (AIHW 2020b).
In 2016, there were 2,170 new cases of liver cancer diagnosed in Australia (1,596 males and 573 females). In 2020, it is estimated that 2,662 new cases of liver cancer will be diagnosed in Australia (1,923 males and 739 females).
In 2018, there were 2,104 deaths from liver cancer in Australia (1,414 males and 690 females). In 2020, it is estimated that there will be 2,297 deaths (1,509 males and 788 females).
In 2012–2016, individuals diagnosed with liver cancer had a 20% chance (20% for males and 17% for females) of surviving for five years compared to their counterparts in the general Australian population.
At the end of 2015, there were 1,379 people living who had been diagnosed with liver cancer that year, 3,431 people living who had been diagnosed with liver cancer in the previous 5 years.